Invention Grant
- Patent Title: Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells
-
Application No.: US16931003Application Date: 2020-07-16
-
Publication No.: US12065671B2Publication Date: 2024-08-20
- Inventor: Kapil Bharti , Lucas Chase , Feng Xuezhu , Balendu Shekhar Jha
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services , FUJIFILM Cellular Dynamics, Inc.
- Applicant Address: US MD Bethesda
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,FUJIFILM Cellular Dynamics, Inc.
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,FUJIFILM Cellular Dynamics, Inc.
- Current Assignee Address: US MD Bethesda; US WI Madison
- Agency: Klarquist Sparkman, LLP
- Main IPC: C12N5/079
- IPC: C12N5/079
Abstract:
Provided herein are methods of producing an RPE cell population from a starting cell suspension, such as a single cell suspension, of pluripotent stem cells (PSCs). Such a method may comprise culturing the starting single cell suspension of PSCs in differentiation media to produce human RPE cells.
Public/Granted literature
- US20210139847A1 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS Public/Granted day:2021-05-13
Information query
